NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,009 filers reported holding NOVARTIS A G in Q1 2018. The put-call ratio across all filers is 0.56 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $863,000 | +0.8% | 10,063 | +1.2% | 0.40% | +4.1% |
| Q3 2018 | $856,000 | +12.8% | 9,940 | -1.1% | 0.39% | +19.5% |
| Q2 2018 | $759,000 | -13.8% | 10,048 | -7.7% | 0.32% | -21.4% |
| Q1 2018 | $881,000 | -5.9% | 10,892 | -2.3% | 0.41% | -7.0% |
| Q4 2017 | $936,000 | -2.1% | 11,146 | +0.1% | 0.44% | -4.3% |
| Q3 2017 | $956,000 | +5.5% | 11,131 | +2.5% | 0.46% | +3.1% |
| Q2 2017 | $906,000 | +6.8% | 10,859 | -4.9% | 0.45% | +8.5% |
| Q1 2017 | $848,000 | +47.7% | 11,424 | +84.3% | 0.41% | +25.2% |
| Q4 2014 | $574,000 | -0.7% | 6,198 | +0.9% | 0.33% | -1.8% |
| Q3 2014 | $578,000 | +9.5% | 6,140 | +5.2% | 0.34% | -1.2% |
| Q2 2014 | $528,000 | -28.1% | 5,834 | -32.4% | 0.34% | -31.3% |
| Q1 2014 | $734,000 | -54.1% | 8,630 | -56.7% | 0.50% | -52.1% |
| Q4 2013 | $1,600,000 | +11.8% | 19,909 | +6.7% | 1.03% | -1.5% |
| Q3 2013 | $1,431,000 | +12.4% | 18,651 | +3.6% | 1.05% | +8.4% |
| Q2 2013 | $1,273,000 | – | 17,998 | – | 0.97% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |